ArticleInternational journal of molecular sciences2022

HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny.

Yurika Nakagawa-Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.